KASEY FRYE: Open Payments
NPI 1609058908 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$175 in 9 payments from 6 companies in 2025. Trend: 2023 $81 · 2024 $308 · 2025 $175
Food & beverage: $175
| Company | Payments | Amount |
|---|---|---|
| LivaNova USA, Inc. | 4 | $70 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $30 |
| ABBVIE INC. | 1 | $22 |
| EMD Serono, Inc. | 1 | $21 |
| Abbott Laboratories | 1 | $17 |
| Gilead Sciences, Inc. | 1 | $15 |
Products named: VNS THERAPY SENTIVA MODEL 1000 GENERATOR, JOURNAVX, RINVOQ, PROCLAIM.
Industry payments across TX — which companies pay providers there.
